Update! HXP-GPOVac Covid-19 vaccine trial phase 2 this August, focusing on booster needles

by time news

The Government Pharmaceutical Organization (GPO) reveals that the HXP-GPOVac vaccine will be tested by Thai people together with the PATH organization for a phase two trial in mid-August to develop a formula to protect against Omicron. Expected to test the samples even though they had never been vaccinated. and receive a booster vaccination in design Initially ready to inject people in the middle of 66

On June 9, 2022, Mrs. Sirinut Chiwanphisannukul Deputy Director of the Government Pharmaceutical Organization (GPO) discussed the progress of the development and production of the HXP-GPOVac vaccine that the Government Pharmaceutical Organization received support from the PATH organization in the development of the HXP-GPOVac vaccine by the PATH organization. Submit a prototype vaccine which was developed by the Mount Sinai School of Medicine. and the University of Texas at Austin. united states come to produce at the biomaterial factory of the Government Pharmaceutical Organization at Thap Kwang Subdistrict, Kaeng Khoi District, Saraburi Province

However, this vaccine is produced using incubation technology. It is a combination method by using the Newcastle virus. Together with Hexapro technology, the stabilization of thorn proteins is a hybrid NDV-HXP-S virus that can be used to stimulate the body to develop immunity against COVID-19.

“In the beginning we tested it on rats. found to be safe good performance Then there were first and second phase human trials. However, formulations that protect against omikron are now being developed. and will return to do phase two again in August When successful, it will continue in the third phase. which is expected will be able to start injecting in people in the middle of 2023,” said Ms. Sirinut.

The reporter asked if the vaccination in the volunteers now had to focus on the booster needle. Deputy director of the district office said that it is currently in the process of applying for registration with the Food and Drug Administration. Which has this issue as well, because really, the second phase of the experiment There may be volunteers who have never been vaccinated at all. with the vaccination as a booster Currently we are designing an experimental model. If you can’t find volunteers who have never been vaccinated at all It is necessary to focus on intense stimulation. which are being considered

* can follow And share Hfocus news at https://www.facebook.com/Hfocus.org

You may also like

Leave a Comment